Eiger BioPharmaceuticals News - EIGR

Company Name	Stock Ticker Symbol	Market	Type
Eiger BioPharmaceuticals Inc	EIGR	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.725	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				1.725

more quote information »

Recent News

Date	Time	Source	Heading
4/01/2024	11:12	GLOBE	Eiger BioPharmaceuticals Files for Voluntary Chapter 11..
3/11/2024	16:03	EDGAR2	Form 8-K - Current report
1/24/2024	16:59	EDGAR2	Form 8-K - Current report
1/18/2024	17:49	PRNUS	Eiger and Partner, AnGes, Receive Approval for Zokinvy®..
1/08/2024	07:00	EDGAR2	Form 8-K - Current report
1/04/2024	08:45	EDGAR2	Form 8-K - Current report
1/04/2024	08:00	PRNUS	Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse..
12/11/2023	16:01	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/04/2023	06:01	EDGAR2	Form SC 13D/A - General statement of acquisition of..
12/01/2023	16:02	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/24/2023	06:01	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
11/13/2023	16:01	EDGAR2	Form 8-K - Current report
11/09/2023	16:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:14	EDGAR2	Form 8-K - Current report
11/09/2023	16:05	PRNUS	Eiger BioPharmaceuticals Reports Third Quarter 2023..
11/02/2023	21:54	EDGAR2	Form SC 13D/A - General statement of acquisition of..
11/02/2023	21:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/30/2023	16:51	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/20/2023	16:29	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
9/28/2023	16:54	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
9/12/2023	17:17	DJN	Eiger BioPharmaceuticals to Discontinue Chronic Hepatitis..
9/12/2023	16:42	EDGAR2	Form 8-K - Current report
9/12/2023	16:05	PRNUS	Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon..
9/05/2023	21:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	21:35	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/05/2023	16:05	PRNUS	Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th..
8/15/2023	06:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/14/2023	16:24	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:09	EDGAR2	Form 8-K - Current report
8/14/2023	16:05	PRNUS	Eiger BioPharmaceuticals Reports Second Quarter 2023..
7/28/2023	16:17	EDGAR2	Form 8-K - Current report
7/07/2023	16:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
7/06/2023	17:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/30/2023	16:16	EDGAR2	Form 8-K - Current report
6/29/2023	08:00	PRNUS	Eiger BioPharmaceuticals to Focus on Metabolic Diseases with..
6/28/2023	16:05	PRNUS	Eiger BioPharmaceuticals to Host Business Update Call..
5/11/2023	16:00	PRNUS	Eiger BioPharmaceuticals Reports First Quarter 2023..
5/03/2023	16:05	PRNUS	Eiger BioPharmaceuticals Reports Inducement Grant Under..